Leming Pharmaceutical

Leming Pharmaceutical is a specialty pharmaceutical company based in Suzhou, China, focused on the development and commercialization of advanced transdermal drug delivery systems (TDDS). The company specializes in high-barrier topical formulations, particularly for pain management and musculoskeletal conditions. Leming's portfolio includes commercialized products such as flurbiprofen cataplasms and a robust pipeline featuring lidocaine and loxoprofen patches. With integrated R&D and large-scale GMP manufacturing capabilities, the company aims to provide effective, localized therapeutic alternatives to systemic medications. Leming is positioned as a leader in the Chinese topical drug market, leveraging proprietary hydrogel and adhesive technologies.